(ZYME) Investment Analysis and Advice - news.stocktradersdaily.com
7 hours ago • Google News
Zymeworks Inc. Common Stock (ZYME)
US$ 12.570.4%
Price Chart
Key Statistics
Market Cap
$ 881.5M
P/E Ratio
0.00
Revenue (TTM)
$ 93.38M
Volume
351.23K
52W High
$ 17.70
52W Low
$ 8.21
Dividend Yield
0.00%
Beta
1.18
Technicals
50-Day MA
11.8365
200-Day MA
13.1017
52 Week High
17.7
52 Week Low
8.21
About ZYME
Zymeworks Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID).
Employees
299
Headquarters
Middletown, DE
CEO
Mr. Kenneth H. Galbraith C.A.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg